Search research articles
Contact Us
Filters
Showing results (61-70 of 99) with videos related to
Page
of 10
Sort By:
Bone Marrow Transplantation
|
April 1, 1992
High-dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: a phase II study
C Kalifa, O Hartmann, F Demeocq, et al.
Clinical Pharmacology and Therapeutics
|
March 30, 2007
Elevated plasma ferritin and busulfan pharmacodynamics during high-dose chemotherapy regimens in children with malignant solid tumors
J Bouligand, A Le Maitre, D Valteau-Couanet, et al.
Cancer Gene Therapy
|
May 29, 2002
Human growth hormone gene transfer into tumor cells may improve cancer chemotherapy
C Cherbonnier, O Déas, G Vassal, et al.
Archives Francaises De Pediatrie
|
November 1, 1992
[Granulosa cell tumors of the ovary in children and adolescents. Multicenter retrospective study in 40 patients aged 7 months to 22 years]
D Plantaz, F Flamant, G Vassal, et al.
Cancer Research
|
April 1, 1993
Chronopharmacology of high-dose busulfan in children
G Vassal, D Challine, S Koscielny, et al.
Cancer Research
|
October 1, 1990
Dose-dependent neurotoxicity of high-dose busulfan in children: a clinical and pharmacological study
G Vassal, A Deroussent, O Hartmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1993
Combined continuous infusion etoposide with high-dose cyclophosphamide for refractory neuroblastoma: a phase II study from the Société Française d'Oncologie Pédiatrique
V Méresse, G Vassal, J Michon, et al.
Biochimie
|
June 6, 1998
Preclinical development of camptothecin derivatives and clinical trials in pediatric oncology
G Vassal, C Pondarré, I Boland, et al.
Pathologie-Biologie
|
September 1, 1988
[Prophylaxis of Gram-positive infections after bone marrow graft. Controlled study of the 6-day administration of vancomycin. Intermediate analysis of 60 patients]
D Maraninchi, O Hartman, E Benhamou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 1998
Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: a prospective assessment
F Saliba, R Hagipantelli, J L Misset, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 99) with videos related to
Sort By:
Page
of 10
Bone Marrow Transplantation
|
April 1, 1992
High-dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: a phase II study
C Kalifa, O Hartmann, F Demeocq, et al.
Clinical Pharmacology and Therapeutics
|
March 30, 2007
Elevated plasma ferritin and busulfan pharmacodynamics during high-dose chemotherapy regimens in children with malignant solid tumors
J Bouligand, A Le Maitre, D Valteau-Couanet, et al.
Cancer Gene Therapy
|
May 29, 2002
Human growth hormone gene transfer into tumor cells may improve cancer chemotherapy
C Cherbonnier, O Déas, G Vassal, et al.
Archives Francaises De Pediatrie
|
November 1, 1992
[Granulosa cell tumors of the ovary in children and adolescents. Multicenter retrospective study in 40 patients aged 7 months to 22 years]
D Plantaz, F Flamant, G Vassal, et al.
Cancer Research
|
April 1, 1993
Chronopharmacology of high-dose busulfan in children
G Vassal, D Challine, S Koscielny, et al.
Cancer Research
|
October 1, 1990
Dose-dependent neurotoxicity of high-dose busulfan in children: a clinical and pharmacological study
G Vassal, A Deroussent, O Hartmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1993
Combined continuous infusion etoposide with high-dose cyclophosphamide for refractory neuroblastoma: a phase II study from the Société Française d'Oncologie Pédiatrique
V Méresse, G Vassal, J Michon, et al.
Biochimie
|
June 6, 1998
Preclinical development of camptothecin derivatives and clinical trials in pediatric oncology
G Vassal, C Pondarré, I Boland, et al.
Pathologie-Biologie
|
September 1, 1988
[Prophylaxis of Gram-positive infections after bone marrow graft. Controlled study of the 6-day administration of vancomycin. Intermediate analysis of 60 patients]
D Maraninchi, O Hartman, E Benhamou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 1998
Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: a prospective assessment
F Saliba, R Hagipantelli, J L Misset, et al.
Page
of 10